ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Nilotinib vs Imatinib in Adult Patients With Philadelphia (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

ClinicalTrials.gov ID: NCT00519090

Public ClinicalTrials.gov record NCT00519090. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 6:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Randomized, Open- Label Multi-center Study of Nilotinib Versus Imatinib in Adult Patients With Ph+ Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) Who Have a Suboptimal Cytogenetic Response (CyR) on Imatinib

Study identification

NCT ID
NCT00519090
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
6 participants

Conditions and interventions

Interventions

  • Imatinib Drug
  • Nilotinib (AMN107) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2007
Primary completion
Sep 30, 2008
Completion
Sep 30, 2008
Last update posted
Nov 6, 2011

2007 – 2008

United States locations

U.S. sites
36
U.S. states
16
U.S. cities
35
Facility City State ZIP Site status
Arizona Cancer Center Tucson Arizona 85701
Southern California Permanente Medical Group Anaheim California 92801
Southern California Permanente Medical Group Baldwin Park California 91706
Southern California Permanente Medical Group Fontana California 92334
Kaiser Permanente Medical Group/Hayward Medical Center Hayward California 94540
Southern California Permanente Medical Group Los Angeles California 90001
Kaiser Permanente Medical Group/Oakland Medical Center Oakland California 94601
Southern California Permanente Medical Group Panorama City California 91402
Southern California Permanente Medical Group Riverside California 92501
Kaiser Permanente Medical Group/Sacramento Medical Center Sacramento California 94203
Southern California Permanente Medical Group San Diego California 92101
Kaiser Permanente Medical Group San Francisco California 94101
Kaiser Permanente Medical Group San Jose California 95101
Kaiser Permanente Medical Group/Santa Clara Medical Office Santa Clara California 95050
Kaiser Permanente Medical Group/South San Francisco Medical Center South San Francisco California 94101
Kaiser Permanente Medical Group/Vallejo Medical Center Vallejo California 94589
Kaiser Permanente Medical Group/Walnut Creek Medical Center Walnut Creek California 94595
Southen California Permanente Medical Group Woodland Hills California 91364
Rocky Mountain Cancer Center Denver Colorado 80201
Northwestern Memorial Hospital Chicago Illinois 60601
The University of Chicago Medical Center Chicago Illinois 60601
Indiana Blood and Marrow Transplantation Beech Grove Indiana 46107
Holden Cancer Center Iowa City Iowa 52240
Johns Hopkins Hospital Baltimore Maryland 21201
University of Michigan Ann Arbor Michigan 48103
Hematology Centers of Western Michigan Grand Rapids Michigan 49501
Methodist Cancer Center Omaha Nebraska 68101
The Cancer Center at Hackensack University Medical Center Hackensack New Jersey 07601
Duke University Hospital Durham North Carolina 27701
Wake Forest University Health Sciences Winston-Salem North Carolina 27101
Oregon Health Sciences University Portland Oregon 97201
St. Luke's Hospital and Health Network Bethlehem Pennsylvania 18015
Jones Cancer Center Germantown Tennessee 38138
Vanderbilt University Nashville Tennessee 37201
University of Texas/MD Anderson Cancer Center Houston Texas 77001
Swedish Cancer Institute Seattle Washington 98101

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00519090, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 6, 2011 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00519090 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →